Gao Xiaoyan, Li Xiaolong, Li Minghua, Fu Shihong, Wang Huanyu, Lu Zhi, Cao Yuxi, He Ying, Zhu Wuyang, Zhang Tingting, Gould Ernest A, Liang Guodong
State Key Laboratory for Infectious Disease Prevention and Control, National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing, People's Republic of China; Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, Hangzhou, People's Republic of China.
Unité des Virus Emergents, Aix-Marseille University Faculté de Médecine de Marseille, Marseille, France.
PLoS Negl Trop Dis. 2014 Aug 14;8(8):e3015. doi: 10.1371/journal.pntd.0003015. eCollection 2014 Aug.
Japanese encephalitis (JE) is arguably one of the most serious viral encephalitis diseases worldwide. China has a long history of high prevalence of Japanese encephalitis, with thousands of cases reported annually and incidence rates often exceeding 15/100,000. In global terms, the scale of outbreaks and high incidence of these pandemics has almost been unique, placing a heavy burden on the Chinese health authorities. However, the introduction of vaccines, developed in China, combined with an intensive vaccination program initiated during the 1970s, as well as other public health interventions, has dramatically decreased the incidence from 20.92/100,000 in 1971, to 0.12/100,000 in 2011. Moreover, in less readily accessible areas of China, changes to agricultural practices designed to reduce chances of mosquito bites as well as mosquito population densities have also been proven effective in reducing local JE incidence. This unprecedented public health achievement has saved many lives and provided valuable experience that could be directly applicable to the control of vector-borne diseases around the world. Here, we review and discuss strategies for promotion and expansion of vaccination programs to reduce the incidence of JE even further, for the benefit of health authorities throughout Asia and, potentially, worldwide.
日本脑炎(JE)可以说是全球最严重的病毒性脑炎疾病之一。中国长期以来日本脑炎高发,每年报告数千例病例,发病率常常超过15/10万。从全球范围来看,这些大流行病的爆发规模和高发病率几乎是独一无二的,给中国卫生当局带来了沉重负担。然而,中国自主研发的疫苗的引入,再加上20世纪70年代启动的强化疫苗接种计划以及其他公共卫生干预措施,已使发病率从1971年的20.92/10万大幅降至2011年的0.12/10万。此外,在中国一些交通不便的地区,旨在减少蚊虫叮咬几率和蚊虫种群密度的农业生产方式的改变,也已被证明在降低当地日本脑炎发病率方面有效。这一前所未有的公共卫生成就挽救了许多生命,并提供了可直接应用于全球病媒传播疾病防控的宝贵经验。在此,我们回顾并讨论进一步推广和扩大疫苗接种计划以降低日本脑炎发病率的策略,以造福亚洲乃至全球的卫生当局。